{"title":"银屑病关节炎和 COVID-19。","authors":"Hinpetch Daungsupawong, Viroj Wiwanitkit","doi":"10.3899/jrheum.2023-0864","DOIUrl":null,"url":null,"abstract":"We would like to share our ideas on the recently published article, \"Psoriatic arthritis and COVID-19: Patient perspectives in a large psoriatic arthritis cohort.\"<sup>1</sup> The purpose of this study was to determine the prevalence of the coronavirus disease 2019 (COVID-19) infection among patients with psoriatic arthritis (PsA), understand patients' opinions on their risk of COVID-19 infection, and evaluate the quality of virtual treatment offered during the pandemic's early phases.","PeriodicalId":501812,"journal":{"name":"The Journal of Rheumatology","volume":"177 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Psoriatic Arthritis and COVID-19.\",\"authors\":\"Hinpetch Daungsupawong, Viroj Wiwanitkit\",\"doi\":\"10.3899/jrheum.2023-0864\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"We would like to share our ideas on the recently published article, \\\"Psoriatic arthritis and COVID-19: Patient perspectives in a large psoriatic arthritis cohort.\\\"<sup>1</sup> The purpose of this study was to determine the prevalence of the coronavirus disease 2019 (COVID-19) infection among patients with psoriatic arthritis (PsA), understand patients' opinions on their risk of COVID-19 infection, and evaluate the quality of virtual treatment offered during the pandemic's early phases.\",\"PeriodicalId\":501812,\"journal\":{\"name\":\"The Journal of Rheumatology\",\"volume\":\"177 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-02-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"The Journal of Rheumatology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.3899/jrheum.2023-0864\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"The Journal of Rheumatology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3899/jrheum.2023-0864","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
We would like to share our ideas on the recently published article, "Psoriatic arthritis and COVID-19: Patient perspectives in a large psoriatic arthritis cohort."1 The purpose of this study was to determine the prevalence of the coronavirus disease 2019 (COVID-19) infection among patients with psoriatic arthritis (PsA), understand patients' opinions on their risk of COVID-19 infection, and evaluate the quality of virtual treatment offered during the pandemic's early phases.
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
